Zoetis was granted a conditional license for its avian influenza vaccine for use in chickens. It's a step closer to fighting the bird flu outbreaks that continue to devastate flocks.

DELMARVA - The U.S. Department of Agriculture has granted a conditional license for drug company Zoetis' vaccine for avian influenza.

Vaccinating livestock and poultry for the H5 series of avian influenza viruses does not have support from the entire ag sector. Friday, Zoetis announced USDA issued a conditional license for it’s killed virus-derived vaccine labeled for use in chickens.

Zoetis, an animal health company, confirmed that the conditional vaccine was approved on Feb. 14. “When a new strain of HPAI was identified in the US in early 2022, our scientists immediately began work to update our previous avian influenza vaccine,

The vaccine from Zoetis, Avian Influenza Vaccine, H5N2 Subtype, Killed Virus, is for poultry and has been demonstrated to be safe, pure, and to have a reasonable expectation of efficacy

Zoetis on Feb. 14 received a conditional license from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus.

Bird flu has infected more than 150 million birds and close to 70 people in the U.S. since it began Egg prices are expected to rise 20% in 2025 due to the outbreak

With egg prices soaring, the US is considering vaccinating laying chickens, which have been hit particularly hard by the avian influenza outbreak.

DELMARVA - The U.S. Department of Agriculture has granted a conditional license for drug company Zoetis' vaccine for avian influenza.

Newly confirmed US Department of Agriculture (USDA) Secretary Brooke Rollins, JD, today introduced new steps to battle avian flu in poultry and stabilize the egg supply, which includes $500 million to help poultry producers shore up biosecurity measures.

Zoetis was granted a conditional license for its avian influenza vaccine for use in chickens. It's a step closer to fighting the bird flu outbreaks that continue to devastate flocks.

PARSIPPANY, N.J., February 14, 2025--(BUSINESS WIRE)--Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype ...